Vaccines 2013, 1(4), 444-462; doi:10.3390/vaccines1040444

Chemokines as Cancer Vaccine Adjuvants

1, 2,* email and 2,* email
Received: 22 July 2013; in revised form: 31 August 2013 / Accepted: 26 September 2013 / Published: 16 October 2013
(This article belongs to the Special Issue Dendritic Cell Vaccine)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: We are witnessing a new era of immune-mediated cancer therapies and vaccine development. As the field of cancer vaccines advances into clinical trials, overcoming low immunogenicity is a limiting step in achieving full success of this therapeutic approach. Recent discoveries in the many biological roles of chemokines in tumor immunology allow their exploitation in enhancing recruitment of antigen presenting cells (APCs) and effector cells to appropriate anatomical sites. This knowledge, combined with advances in gene therapy and virology, allows researchers to employ chemokines as potential vaccine adjuvants. This review will focus on recent murine and human studies that use chemokines as therapeutic anti-cancer vaccine adjuvants.
Keywords: chemokines; dendritic cell; immunotherapy; cancer vaccine; adjuvant
PDF Full-text Download PDF Full-Text [1109 KB, Updated Version, uploaded 17 October 2013 18:02 CEST]
The original version is still available [1110 KB, uploaded 16 October 2013 16:13 CEST]

Export to BibTeX |

MDPI and ACS Style

Bobanga, I.D.; Petrosiute, A.; Huang, A.Y. Chemokines as Cancer Vaccine Adjuvants. Vaccines 2013, 1, 444-462.

AMA Style

Bobanga ID, Petrosiute A, Huang AY. Chemokines as Cancer Vaccine Adjuvants. Vaccines. 2013; 1(4):444-462.

Chicago/Turabian Style

Bobanga, Iuliana D.; Petrosiute, Agne; Huang, Alex Y. 2013. "Chemokines as Cancer Vaccine Adjuvants." Vaccines 1, no. 4: 444-462.

Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert